145 related articles for article (PubMed ID: 19574718)
1. Is Stat3 and/or p53 mRNA expression a prognostic marker for renal cell carcinoma?
Masuda A; Kamai T; Abe H; Arai K; Yoshida K
Biomed Res; 2009 Jun; 30(3):171-6. PubMed ID: 19574718
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and expression of PUMA, MCL-1, and p53 in human renal cell carcinoma and para-carcinoma tissues.
Xia HB; Cui HW; Su L; Zhang ZH; Yang XY; Ning SQ; Su XL
Genet Mol Res; 2017 Jul; 16(3):. PubMed ID: 28692117
[TBL] [Abstract][Full Text] [Related]
3. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
4. Significant association of interleukin 10 receptor mRNA levels with renal cell carcinoma metastasis.
Abe H; Yamanishi T; Mashidori T; Arai K; Kamai T
Biomed Res; 2008 Feb; 29(1):19-25. PubMed ID: 18344594
[TBL] [Abstract][Full Text] [Related]
5. Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma.
Furuya N; Kamai T; Shirataki H; Yanai Y; Fukuda T; Mizuno T; Nakamura F; Kambara T; Nakanishi K; Abe H; Yoshida K
Cancer Immunol Immunother; 2011 Jun; 60(6):793-808. PubMed ID: 21350947
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of miR-21 expression is a valuable predicator of advanced clinicopathological features and poor prognosis in patients with renal cell carcinoma through the p53/p21‑cyclin E2‑Bax/caspase-3 signaling pathway.
Liu Z; Lu Y; Xiao Y; Lu Y
Oncol Rep; 2017 Mar; 37(3):1437-1444. PubMed ID: 28184919
[TBL] [Abstract][Full Text] [Related]
7. BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma.
Sekino Y; Han X; Kobayashi G; Babasaki T; Miyamoto S; Kobatake K; Kitano H; Ikeda K; Goto K; Inoue S; Hayashi T; Teishima J; Sakamoto N; Sentani K; Oue N; Yasui W; Matsubara A
Oncology; 2021; 99(4):240-250. PubMed ID: 33588420
[TBL] [Abstract][Full Text] [Related]
8. The IGF-I/JAK2-STAT3/miR-21 signaling pathway may be associated with human renal cell carcinoma cell growth.
Su Y; Zhao A; Cheng G; Xu J; Ji E; Sun W
Cancer Biomark; 2017 Jul; 19(3):289-296. PubMed ID: 28453463
[TBL] [Abstract][Full Text] [Related]
9. Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis.
Kamai T; Yanai Y; Arai K; Abe H; Yamanishi T; Kurimoto M; Yoshida K
BMC Cancer; 2007 Aug; 7():159. PubMed ID: 17697365
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
Sandlund J; Ljungberg B; Wikström P; Grankvist K; Lindh G; Rasmuson T
Acta Oncol; 2009; 48(6):909-14. PubMed ID: 19322701
[TBL] [Abstract][Full Text] [Related]
11. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.
Hofmockel G; Wittmann A; Dammrich J; Bassukas ID
Anticancer Res; 1996; 16(6B):3807-11. PubMed ID: 9042262
[TBL] [Abstract][Full Text] [Related]
12. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 6 induces cell proliferation of clear cell renal cell carcinoma by suppressing hepaCAM via the STAT3-dependent up-regulation of DNMT1 or DNMT3b.
Quan Z; He Y; Luo C; Xia Y; Zhao Y; Liu N; Wu X
Cell Signal; 2017 Apr; 32():48-58. PubMed ID: 28093267
[TBL] [Abstract][Full Text] [Related]
14. Possible role of the RhoC/ROCK pathway in progression of clear cell renal cell carcinoma.
Abe H; Kamai T; Tsujii T; Nakamura F; Mashidori T; Mizuno T; Tanaka M; Tatsumiya K; Furuya N; Masuda A; Yamanishi T; Yoshida K
Biomed Res; 2008 Jun; 29(3):155-61. PubMed ID: 18614849
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 and p53 expression as prognostic indicators in conventional renal cell carcinoma.
Cho DS; Joo HJ; Oh DK; Kang JH; Kim YS; Lee KB; Kim SJ
Yonsei Med J; 2005 Feb; 46(1):133-40. PubMed ID: 15744816
[TBL] [Abstract][Full Text] [Related]
16. Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer.
Wan YP; Xi M; He HC; Wan S; Hua W; Zen ZC; Liu YL; Zhou YL; Mo RJ; Zhuo YJ; Luo HW; Jiang FN; Zhong WD
Oncol Res Treat; 2017; 40(1-2):15-20. PubMed ID: 28118628
[TBL] [Abstract][Full Text] [Related]
17. Non-coding RNA 886 promotes renal cell carcinoma growth and metastasis through the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
Lei J; Xiao JH; Zhang SH; Liu ZQ; Huang K; Luo ZP; Xiao XL; Hong ZD
Mol Med Rep; 2017 Oct; 16(4):4273-4278. PubMed ID: 28765891
[TBL] [Abstract][Full Text] [Related]
18. STAT3 regulates miR93-mediated apoptosis through inhibiting DAPK1 in renal cell carcinoma.
Du Y; Kong C
Cancer Gene Ther; 2021 May; 28(5):502-513. PubMed ID: 33230258
[TBL] [Abstract][Full Text] [Related]
19. Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma.
Awakura Y; Nakamura E; Takahashi T; Kotani H; Mikami Y; Kadowaki T; Myoumoto A; Akiyama H; Ito N; Kamoto T; Manabe T; Nobumasa H; Tsujimoto G; Ogawa O
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1363-9. PubMed ID: 18483744
[TBL] [Abstract][Full Text] [Related]
20. SIRT1 downregulated FGB expression to inhibit RCC tumorigenesis by destabilizing STAT3.
Chen Y; Zhu Y; Sheng Y; Xiao J; Xiao Y; Cheng N; Chai Y; Wu X; Zhang S; Xiang T
Exp Cell Res; 2019 Sep; 382(2):111466. PubMed ID: 31201813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
